FR2763589B1 - Composes pour la preparation de medicaments destines au traitement de pathologies impliquant le glutamate extracellulaire, et leurs procedes d'obtention - Google Patents

Composes pour la preparation de medicaments destines au traitement de pathologies impliquant le glutamate extracellulaire, et leurs procedes d'obtention

Info

Publication number
FR2763589B1
FR2763589B1 FR9706265A FR9706265A FR2763589B1 FR 2763589 B1 FR2763589 B1 FR 2763589B1 FR 9706265 A FR9706265 A FR 9706265A FR 9706265 A FR9706265 A FR 9706265A FR 2763589 B1 FR2763589 B1 FR 2763589B1
Authority
FR
France
Prior art keywords
medicines
compounds
obtaining
processes
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9706265A
Other languages
English (en)
Other versions
FR2763589A1 (fr
Inventor
Jean Marc Kamenka
Isoline Caubere
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR9706265A priority Critical patent/FR2763589B1/fr
Priority to PCT/FR1998/001029 priority patent/WO1998052936A1/fr
Priority to US09/424,208 priority patent/US6514967B1/en
Priority to EP98928355A priority patent/EP0984953A1/fr
Publication of FR2763589A1 publication Critical patent/FR2763589A1/fr
Application granted granted Critical
Publication of FR2763589B1 publication Critical patent/FR2763589B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/76—Dibenzothiophenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9706265A 1997-05-22 1997-05-22 Composes pour la preparation de medicaments destines au traitement de pathologies impliquant le glutamate extracellulaire, et leurs procedes d'obtention Expired - Fee Related FR2763589B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR9706265A FR2763589B1 (fr) 1997-05-22 1997-05-22 Composes pour la preparation de medicaments destines au traitement de pathologies impliquant le glutamate extracellulaire, et leurs procedes d'obtention
PCT/FR1998/001029 WO1998052936A1 (fr) 1997-05-22 1998-05-22 Composes pour la preparation de medicaments destines au traitement de pathologies impliquant le glutamate extracellulaire, et leurs procedes d'obtention
US09/424,208 US6514967B1 (en) 1997-05-22 1998-05-22 Compound for preparing medicines for treating pathologies involving extracellular glutamate, and methods for obtaining same
EP98928355A EP0984953A1 (fr) 1997-05-22 1998-05-22 Composes pour la preparation de medicaments destines au traitement de pathologies impliquant le glutamate extracellulaire, et leurs procedes d'obtention

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9706265A FR2763589B1 (fr) 1997-05-22 1997-05-22 Composes pour la preparation de medicaments destines au traitement de pathologies impliquant le glutamate extracellulaire, et leurs procedes d'obtention

Publications (2)

Publication Number Publication Date
FR2763589A1 FR2763589A1 (fr) 1998-11-27
FR2763589B1 true FR2763589B1 (fr) 2001-01-05

Family

ID=9507124

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9706265A Expired - Fee Related FR2763589B1 (fr) 1997-05-22 1997-05-22 Composes pour la preparation de medicaments destines au traitement de pathologies impliquant le glutamate extracellulaire, et leurs procedes d'obtention

Country Status (4)

Country Link
US (1) US6514967B1 (fr)
EP (1) EP0984953A1 (fr)
FR (1) FR2763589B1 (fr)
WO (1) WO1998052936A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007006178A (es) * 2004-11-23 2007-06-20 Ptc Therapeutics Inc Fenoles substituidos como agentes activos que inhiben la produccion del factor de crecimiento endotelial vascular.
CN115894434A (zh) * 2022-11-14 2023-04-04 山东厚德精诚药业有限公司 一种4-哌嗪基苯并噻吩盐酸盐的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036979A (en) * 1974-01-25 1977-07-19 American Cyanamid Company Compositions containing 4,5,6,7-tetrahydrobenz[b]thien-4-yl-ureas or derivatives and methods of enhancing growth rate
US3972895A (en) * 1974-04-05 1976-08-03 American Cyanamid Company Benzothienylisothiocyanates
US3994924A (en) * 1975-11-04 1976-11-30 American Cyanamid Company 4,5,6,7-Tetra hydro-7-oxobenzo(B)thien-4-yl isocyanate and isothiocyanate
US4154740A (en) * 1976-03-23 1979-05-15 American Cyanamid Company Substituted tetrahydrobenzothiophenes and method of preparation thereof
AU581865B2 (en) * 1983-11-15 1989-03-09 E.I. Du Pont De Nemours And Company Herbicidal substituted-thiophene sulfonamides
GB8516573D0 (en) * 1985-07-01 1985-08-07 Janssen Pharmaceuticaa Nv Controlling weeds
JPS62138489A (ja) * 1985-12-12 1987-06-22 Tokuyama Soda Co Ltd 臭素化チオフエンの製造方法
US4816474A (en) * 1987-02-27 1989-03-28 Ciba-Geigy Corporation Amino substituted thienothiopyran derivatives, composition containing them, and method of using them to stimulate presynaptic dopamine receptors
US4878940A (en) * 1987-04-02 1989-11-07 Janssen Pharmaceutica N.V. Herbicidal 1,5-substituted 1H-imidazoles
EP0314852B1 (fr) * 1987-11-06 1993-11-18 Ciba-Geigy Ag Procédé de préparation d'acide imidazol-1-substitué carbonique et dérivés
FR2639225B1 (fr) * 1988-11-21 1993-05-21 Centre Nat Rech Scient Compositions pharmaceutiques pour la neuroprotection contenant des arylcyclohexylamines
DK640289D0 (da) 1989-12-18 1989-12-18 Ferrosan As Ny heterocyklisk kemi
FR2734819B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
FR2763589A1 (fr) 1998-11-27
WO1998052936A1 (fr) 1998-11-26
US6514967B1 (en) 2003-02-04
EP0984953A1 (fr) 2000-03-15

Similar Documents

Publication Publication Date Title
MA26415A1 (fr) Composes heterocycliques, procede pour la preparation et compositions pharmaceutiques les contenant
EE9600118A (et) Uus peroraalne farmatseutiline annusvorm
ATE206924T1 (de) Oral anzuwendende arzneizubereitung enthaltend olanzapin
FR2761265B1 (fr) Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
FR2806918B1 (fr) Catheter pour l'administration specifique d'un medicament
MA26516A1 (fr) Tartrate d'un dipeptide substitue, procede pour sa preparation et compositions pharmaceutiques le contenant.
MA26608A1 (fr) Procede de preparation d'une composition pharmaceutique destinee au traitement de l'insuffisance cardiaque.
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
FR2796945B1 (fr) Nouveaux derives d'hydantoines, de thiohydantoines, de pyrimidinediones et de thioxopyrimidinones, leurs procedes de preparation et leur application a titre de medicaments
DZ2316A1 (fr) Micro sphères pharmaceutiques d'acide valproique pour administration orale.
FR2747678B1 (fr) Composes derives d'imidazobenzoxazine, leurs procedes de preparation et leurs utilisations en therapeutique
FR2687401B1 (fr) Derives de la 1,4-dialkylpiperazine, procedes d'obtention et compositions pharmaceutiques les contenant.
IT1303805B1 (it) Cotile da revisione per impiego nel trattamento di patologiedell'anca.
FR2763589B1 (fr) Composes pour la preparation de medicaments destines au traitement de pathologies impliquant le glutamate extracellulaire, et leurs procedes d'obtention
MA26645A1 (fr) Composes destines au traitement des troubles psychiotriques, neurologiques et physiologiques lies au recepteur de l'orphanine fq
NO975680L (no) Oralt, farmasöytisk preparat av piperidinoalkanol-forbindelser i opplösningsform
MA26643A1 (fr) Nouveaux composes pour la preparation de medicaments pour le traitement de maladies associees au recepteur orphanine fq
TNSN98206A1 (fr) Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
FR2716623B1 (fr) Utilisation d'un dérivé tricyclique pour l'obtention de médicaments destinés au traitement des troubles mnémo-cognitifs.
FR2795323B1 (fr) Utilisation de ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention ou au traitement des pathologies du systeme gastrointestinal
NO20011103D0 (no) Lokal avlevering av legemidler til hjertet
FR2759906B1 (fr) Utilisation de milnacipran et de ses derives pour la preparation d'un medicament destine au traitement de certaines maladies psychiatriques
FR2792199B3 (fr) Utilisation de l'osanetant pour la preparation de medicaments utiles dans le traitement des troubles de l'humeur
FR2720944B1 (fr) Composition thérapeutique ou diététique sous forme de gel médicamenteux pour l'administration à des animaux de compagnie.
RU97120756A (ru) Применение форсколина или экстрактов, содержащих его, для производства лекарственного препарата для лечения хронического алкоголизма

Legal Events

Date Code Title Description
ST Notification of lapse